10th Joint ACTRIMS-ECTRIMS Meeting
The 10th Joint ACTRIMS‑ECTRIMS Global Meeting in Toronto, Canada, will bring together the international multiple sclerosis community to share the latest advances in research, clinical practice, and innovation. The meeting provides an important forum for discussing emerging insights into MS disease mechanisms, including viral and immunological factors relevant to EBV‑MS research.
ACTRIMS (Americas Committee for Treatment and Research in MS) and ECTRIMS (European Committee for Treatment and Research in MS) collaborates closely, and together they will organize the Joint ACTRIMS-ECTRIMS Global meeting in Toronto, Canada.
The meeting is expected to attract a broad audience of researchers, clinicians, and early‑career scientists from across the global MS community. The scientific program will cover a wide range of topics, including MS pathogenesis, disease progression, biomarkers, and therapeutic strategies. Particular emphasis is placed on translational research and the integration of basic, clinical, and population‑based studies. For the EBV‑MS research community, the meeting represents an important opportunity to engage with emerging data on environmental, viral, and immunological factors contributing to MS.
ACTRIMS‑ECTRIMS meetings are known for their high scientific quality and interactive formats, including plenary lectures, oral abstract sessions, and poster presentations. The conference also provides valuable opportunities for networking and collaboration across disciplines and geographic regions.
Further information about the program, registration, and abstract submission is available on the conference website.